🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Recruitingn/aAges 50 Years - anyAllSkyline Therapeutics
NCT06346600 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All subject who completed the parent clinical study (NCT06213038 and NCT05986864) will undergo safety and efficacy assessments up to 5 years post study drug injection.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Subjects who only meet all of the following criteria are eligible for this study: * nAMD subjects who have been enrolled in the SKG0106-related study and received SKG0106 injection; * Subjects who voluntarily sign an informed consent form (ICF) and comply with the protocol to complete the study Exclusion Criteria: * Subjects who are judged by the investigator unsuitable for this study
💊

What it tests

  • SKG0106
📍

Where

10 sites
Ophthalmic Consultants of Boston
Boston, United States
Retina Consultants of Texas
Katy, United States
Wagner Macula & Retina Center
Norfolk, United States
The Second Hospital Of Anhui Medical University
Hefei, China
Zhejiang Provincial People's Hospital
Hangzhou, China
Eye Hospital, WMU (Zhejiang Eye Hospital)
Wenzhou, China
Beijing Hospital
Beijing, China
Peking Union Medical College Hospital
Beijing, China

…and 2 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy